Cette page est disponible uniquement en anglais

Deal or Case news
13.06.2024
Our firm assisted Nyxoah, a medical technology company focused on solutions to treat Obstructive Sleep Apnea (OSA), in its underwritten public offering in the United States, which included shares sold in a private offering to certain investors within the European Union. Nyxoah sold 5,674,755 shares at an offering price of USD 9.25 (EUR 8.54) per share.
We are pleased to have assisted our longstanding client Nyxoah in this significant transaction as they continue their journey to advance treatments to address OSA.
Philippe Remels, Corporate/M&A partner

Nyxoah sold 5,674,755 shares at an offering price of USD 9.25 (EUR 8.54) per share. Total gross proceeds of the offering amount to approximately USD 52.5 million (EUR 48.5 million), including the exercise of the underwriters’ option to purchase additional shares for 300,000 shares and before deducting underwriting discounts and commissions and offering expenses.

Nyxoah intends to use the net proceeds from the proposed offering (i) for pre-commercialisation and commercialisation activities in the United States; (ii) to continue gathering clinical data and to support physician initiated clinical research projects related to OSA patient treatments; (iii) to further finance research and development activities related to the next generation of the Genio system and to continue to build a pipeline of new technologies and explore potential collaboration opportunities in the field of monitoring and diagnostics for OSA; and (iv) for other general corporate purposes, including, but not limited to, working capital, capital expenditures, investments, acquisitions, should Nyxoah choose to pursue any, and collaborations. The official press release can be found here.

Philippe Remels led the NautaDutilh team, which further consisted of Lentle Nijs and Don Baudewyns.

Notification de cookies

Cette fonctionnalité utilise des cookies tiers. Modifiez votre cookie préférences pour visualiser ce contenu ou afficher plus d'informations.
Ces cookies assurent le bon fonctionnement du site. Ces cookies ne peuvent pas être désactivés.
Ces cookies peuvent être placés par des tiers, tels que YouTube ou Vimeo.
En désactivant certaines catégories, les fonctionnalités associées au sein du site risquent de ne plus fonctionner correctement. Vous pouvez modifier vos préférences ultérieurement. Voir plus d'informations.